口服抗血小板药物对冠心病患者的治疗效果

Effect of Oral Antiplatelet Drugs in the Treatment of Patients with Coronary Heart Disease(CHD)

目的探究为冠心病患者提供抗血小板药物的疗效,以便为临床治疗提供科学依据。方法根据2015年7月-2016年7月到我院接受治疗的80例冠心病患者的临床资料为研究对象,将其随机分成治疗组(抗血小板药物)与对比组(氯吡格雷药物),每组40例,比较治疗前后两组患者血小板平均凝聚率、反应指数以及不良反应状况。结果治疗后,两组患者的各项指标均得到有效改善,但治疗组中患者血小板的凝聚率与反应指数好转情况均优于对比组,并且治疗组不良反应发生率为2.5%,低于对比组32.5%,差异有统计学意义(P<0.05)。结论在临床治疗冠心病患者中,口服抗血小板药物不仅能帮助患者获得良好的治疗效果,而且有较高的安全价值,应推广使用范围。

Objective To explore the curative effect of antiplatelet drugs for coronary heart disease （CHD） patients, so as to provide a scientific basis for clinical treatment. Methods 80 patients with coronary heart disease （CHD） were selected from July 2015 to July 2016 to our hospital for treatment of the clinical data as the research objects, they were random divided into treatment group （antiplatelet drugs） and contrast group （clopidogrel drug）, each group had 40 patients, the platelet average condensation rate and adverse reaction condition, reaction index of two groups before and after the treatment were compared. Results After treatment, the indicators of two groups of patients were effectively improved, but the treatment group of patients with platelet coagulation rate and reaction index improvements were better than the control group, and the adverse reaction rate of the treatment group was 2.5%, which was higher than the comparison group 32.5%. there were significant difference between two groups （P〈0.05）. Conclusion In clinical treatment of coronary heart disease patients, oral antiplatelet drugs not only can help patients get good treatment effect, and high security value, should promote the use scope.